Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2025 09:54 ET | Source: Research and Markets

Enbrel (Etanercept) Market Research Report 2025: Epidemiology, Pipeline Analysis, Insights & Forecasts 2019-2024, 2024-2029F, 2034F

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Enbrel (Etanercept) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ...
February 12, 2025 04:04 ET | Source: Research and Markets

$22.68 Bn Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has been added to ...
September 26, 2024 04:17 ET | Source: Research and Markets

U.S. Psoriasis Treatment Awareness & Satisfaction Report: A Review of 2023 - Provides Valuable Insights Into Must-Have Patient-Reported Data Points

Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Psoriasis in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...
September 19, 2024 10:21 ET | Source: Research and Markets

Etanercept Biosimilar Insight Market Report 2024: Pipeline Analysis, Therapeutic Assessment, Sales Assessment, Unmet Needs, and Impact of Drugs

Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Etanercept - Biosimilar Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This "Etanercept - Biosimilar Insight, 2024" report...
May 31, 2024 06:46 ET | Source: Research and Markets

Global Biosimilars and Follow-On Biologics Market Report 2024-2034 - Expanding the Portfolio of Biosimilars for Rare Diseases

Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars and Follow-On Biologics Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Biosimilars and...
January 17, 2023 07:38 ET | Source: Research and Markets

Brazil Anti-Rheumatic Drug Market Forecasts Report 2022: A $2.83 Billion Market by 2027 - Aging Populations Driving Demand

Dublin, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The "Brazil Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.The Brazilian...
January 11, 2023 04:48 ET | Source: Research and Markets

Adalimumab, Infliximab And Etanercept Biosimilars Global Market Report 2023: Increasing Healthcare Access Bolsters Sector

Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ...
May 10, 2022 11:43 ET | Source: Facts & Factors

At CAGR of 3.3% Global Etanercept Market Size & Share | 2022 - 2028 | Projected to Hit at USD 20.8 Billion: Etanercept Industry Trends, Value, Analysis & Forecast Report by Facts & Factors

NEW YORK, United States, May 10, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Etanercept Market By Application (Juvenile Idiopathic Arthritis, Rheumatoid...
June 15, 2021 08:00 ET | Source: Scipher Medicine Corporation

Scipher Medicine Presents New Data at the European League Against Rheumatism (EULAR) 2021 Further Validating PrismRA® Test

Molecular signature test predicts likelihood of non-response to adalimumab or etanercept, two of the world’s most expensive medications, in an independent validation cohort PrismRA demonstrates a more...
March 29, 2021 04:53 ET | Source: Research and Markets

Global TNF Alpha Inhibitors Market Report 2020: Market is Expected to Recover and Reach $42.86 Billion in 2023 - Long-term Forecast to 2025 & 2030

Dublin, March 29, 2021 (GLOBE NEWSWIRE) -- The "TNF Alpha Inhibitors Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. The global...

Next Page keyboard_arrow_right